Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the
EMPULSE
trial
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-20
DOI
10.1002/ejhf.2137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial
- (2021) Michael E. Nassif et al. CIRCULATION
- SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
- (2020) Milton Packer DIABETES CARE
- Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)
- (2020) Kevin Damman et al. EUROPEAN JOURNAL OF HEART FAILURE
- Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study
- (2020) Jasper Tromp et al. Lancet Global Health
- Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
- (2020) Matthew Griffin et al. CIRCULATION
- Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment
- (2020) Eva M. Boorsma et al. Nature Reviews Cardiology
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2020) Stefan D Anker et al. EUROPEAN HEART JOURNAL
- Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. The position paper of the Heart Failure Association of the European Society of Cardiology
- (2020) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Use of the Win Ratio in Cardiovascular Trials
- (2020) João Pedro Ferreira et al. JACC-Heart Failure
- Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial
- (2020) Natalie A. Mordi et al. CIRCULATION
- Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial
- (2020) Milton Packer et al. CIRCULATION
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
- (2020) Eva M. Boorsma et al. EUROPEAN JOURNAL OF HEART FAILURE
- Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
- (2020) Milton Packer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR‐Preserved Trial
- (2020) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- (2020) John R. Teerlink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial
- (2020) Zachary L Cox et al. AMERICAN HEART JOURNAL
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality
- (2019) Gianluigi Savarese et al. CIRCULATION
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events
- (2019) Milton Packer CIRCULATION
- Heart failure around the world
- (2019) Jasper Tromp et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Serelaxin in Patients with Acute Heart Failure
- (2019) Marco Metra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in heart failure: new frontiers
- (2019) Jasper Tromp et al. EUROPEAN JOURNAL OF HEART FAILURE
- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
- (2018) Karin Rådholm et al. CIRCULATION
- Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
- (2018) Petter Bjornstad et al. DIABETES CARE
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion
- (2017) Lucas N.L. Van Aelst et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
- (2017) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
- (2017) Christoph Wanner et al. CIRCULATION
- Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction
- (2016) Yuya Matsue et al. JOURNAL OF CARDIAC FAILURE
- The vulnerable phase after hospitalization for heart failure
- (2015) Stephen J. Greene et al. Nature Reviews Cardiology
- A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
- (2014) J. McMurray et al. EUROPEAN HEART JOURNAL
- Forecasting the Impact of Heart Failure in the United States
- (2013) Paul A. Heidenreich et al. Circulation-Heart Failure
- Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
- (2013) G. Filippatos et al. EUROPEAN HEART JOURNAL
- Why do drugs for acute heart failure fail?
- (2012) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
- (2011) S. J. Pocock et al. EUROPEAN HEART JOURNAL
- Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
- (2011) C.M. O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
- (2010) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now